Aceclofenac in the management of inflammatory pain

Bibliography

• JONES R: Manifesto for the ThirdMillennium. The Patient's Network (2000) 5:Number 3.
   Google Scholar
• DOOLEY M, SPENCER CM, DUNN CJ: Aceclofenac. A reappraisal of its use in the management of pain and rheumatic disease. Drugs (2001) 61:1351–1378.
   Google Scholar
• GONZALEZ-ALVARO I, CARMONA L, DIAZ-GONZALEZ F et al: Aceclofenac, a new nonsteroidal antiinflammatory drug, decreases the expression and function of some adhesion molecules on human neutrophils. Rheumatol. (1996) 23:723–729.
   Google Scholar
• DINGLE JT, PARKER M: NSAID stimulation of human cartilage matrix synthesis. Clin. Drug Invest. (1997) 14:353–362.
   Web of Science ®Google Scholar
• AKIMOTO H, YAMAZAKI R, HASHIMOTO S et al.: 4'-Hydroxyaceclofenac suppresses the interleukin-l-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. Ear. Pharmacol. (2000) 401:429–436.
   Google Scholar
• YAMAZAKI R, KAWAI S, MIZUSHIMA Y et al.: A major metabolite of aceclofenac,4'-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP 1 and pro-stromyelsin-1/proMMP-3 by human rheumatoid synovial cells. Inflamm. Res. (2000) 49:133-138.
   Google Scholar
• HENROTIN Y, DE LEVAL X, MATHY-HARTET M et al.: In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Inflamm. Res. (2001) 50:391-399.
   Google Scholar
• LINDBURY P, VOJNOVIC I, WARNER T: COX-2/COX-1 selectivity of aceclofenac in comparison with celecoxib and rofecoxib in the human whole blood assay. Osteoarthr: Carta. (2000) 8(Suppl. B):S40–S41.
   Google Scholar
• GRAU M, GUASCH J, MONTERO J et al.: Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Arzneim-Forsch (1991) 41:1265–1276.
   Google Scholar
• ARA&O A, ZAPATERO MI, BASI N, DUQUE A, GROPPER S: Comparison of the anti-inflammatory effect and gastrointestinal tolerability of aceclofenac and diclofenac. Arzneim-Forsch (1996) 46:398-400. 11. CREAMER J: A comparison of the pharmacokinetics of single and repeated doses of aceclofenac in young and elderly volunteers. Br.j Clin. Res. (1992) 3:99-107.
   Google Scholar
• CREMA A, CREMA F, PARNHAM MJ et al.: Effect of food on the bioavailability of aceclofenac tablets in healthy volunteers. Ear. J. Gin. Res. (1995) 7:155-160.
   Google Scholar
• BORT R, PONSODA X, CARRASCO E et al.: Metabolism of aceclofenac in humans. Drug Metal,. Dispos. (1996) 24:834-841.
   Google Scholar
• OLIVIERA SA, FELSON DT, REED JI et al.: Incidence of symptomatic hand, hip and knee osteoarthritis among patients in a health management organisation. Arthritic Rheum. (1997) 38:1134-1141.
   Google Scholar
• SANGHA 0: Epidemiology of rheumatic disease. Rheumatology (2000) 39(Suppl. 2):3–12.
   Google Scholar
• PERROT S, MENKES CJ: Nonpharmacological approaches to pain in osteoarthritis. Available options. Drugs (1996) 52:21-26.
   Google Scholar
• WARD DE, VEYS EM, BOWDLER JM, ROMA J: Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis. Clin. Rheumatol. (1995) 14:656-662.
   Google Scholar
• DIAZ C, RODRIGUEZ A, GELI C, LLOBET JM, TAPOUNET R: Comparison of aceclofenac and diclofenac in osteoarthritic pain. Curt: The]: Res. (1988) 44:252-258.
   Google Scholar
• DIAZ C, RODRIGUEZ DE LA SERNA A, GELI C, GRAS X et al.: Efficacy and tolerability of aceclofenac versus diclofenac in the treatment of knee osteoarthritis: a multicentre study. Ear: I Rheumatol. Inflamm. (1996) 16:17-22.
   Google Scholar
• PEREZ BUSQUIER M, CALERO E, RODRIGUEZ M et al: Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis. Clin. Rheumatol. (1997) 16:154–159.
   Google Scholar
• TORRI G, VIGNATI C, AGRIFOGLIO E et al.: Aceclofenac versus piroxicam in the management of osteoarthritis of the knee: a double-blind controlled study. Curt: The]: Res. (1994) 55:576-583.
   Google Scholar
• KORNASOFF D, FRERICK H, BOWDLERJ, MONTULL E: Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis. Rheumatol. (1997) 16:32-38.
   Google Scholar
• SYMMONS DP: Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract. Res. Rheumatol. (2002) 16:707-722.
   Google Scholar
• MARTIN-MOLA E, GIJON-BA&OS J, ANSOLEAGA JJ: Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol. Int. (1995) 15:111-116.
   Google Scholar
• GIORGIANNI G, OTTAVIANI C, SOLIANO A, CAMPI N: Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curt: The]: Res. (1992) 51:175-184.
   Google Scholar
• PASERO G, MARC OLONGO R, SERNI U, PARNHAM MJ, FERRER F: A multicentre, double-blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis. Carr: Med. Res. Opin. (1995) 13:305-315.
   Google Scholar
• KORNASOFF D, MAISENBACHER J, BOWDLERJ, RABER A: The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. Rheumatol. Int. (1996) 15:225–230.
   Google Scholar
• PEREZ-RUIZ F, ALONSO-RUIZ A, ANSOLEAGAJJ: Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis. Rheumatol. (1996) 15:473-477.
   Google Scholar
• HUSKISSON EC, IRANI M, MURRAY F: A large prospective open-label, multicentre SAMM study, comparing the safety of aceclofenac with diclofenac in patients with rheumatic disease. Eur. Rheumatol. Inflamm. (2000) 17:1–7.
   Google Scholar
• VILLA-ALCAZAR LF, DE BUERGO MA, LENZA HR, FRUITOS EM, Spanish Study Group on Aceclofenac in Ankylosing Spondylitis: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a b3 month multicenter comparative trial. Rheumatol. (1996) 23:1194-1199.
   Google Scholar
• PASERO G, RUJU G, MARCOLONGO R ieta].: Aceclofenac versus naproxen in the treatment of ankylosing spondylitis: a double-blind, controlled study. Curr. Ther. Res. (1994) 55:833-842.
   Google Scholar
• BATLLE-GUALDA E, FIGUEROA M, IVORRA J, RABER A: The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac-Indomethacin Study Group. Rheumatol. (1996) 23:1200-1206.
   Google Scholar
• CECCHETTIN M, CEREA P, TORRI G: Therapetic efficacy of aceclofenac and diclofenac in acute knee arthroses. Clin. Trials J. (1988) 25:144-151.
   Google Scholar
• ANDERSSON GBJ: Epidemiology of low back pain. Acta Ortho. Scand. (1998) 69(Suppl.):28–31.
   Google Scholar
• AGRIFOGLIO E, BENVENUTI M, GATTO P et al.: Aceclofenac: a new NSAID in the treatment of acute lumbago. Multicentre single-blind study versus diclofenac. Acta The]: (1994) 20:33-45.
   Google Scholar
• SCHATTENKIRCHNER M, MILACHOWSKI KA: A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin. Rheumatol. (2003) 22:127-135. b37. YSCLA A: Aceclofenac and paracetamol in episiotomal pain. Drugs Exp. Clin. Res. (1988) 14:491–494.
   Google Scholar
• MOVILIA PG: Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of post-episiotomy pain. Drugs Exp. Clin. Res. (1989) 15:47-51.
   Google Scholar
• BUBANI G: The analgesic activity and tolerability of aceclofenac in the treatment of odontalgia: a double-blind placebo-controlled evaluation. Clin. Trials J. (1988) 25:244–253.
   Google Scholar
• SAINZ-OLALLA F: Analgesic efficacy of aceclofenac: double-blind controlled study versus placebo in odontalgia. Carr: Ther. Res. (1988) 43:900–902.
   Web of Science ®Google Scholar
• PUIGVERT TORRENT A: Dose-response study of the analgesic activity of aceclofenac in odontalgia following extraction of the third molar. Drug Invest. (1990) 2:132–136.
   Google Scholar
• DA FONSECA AM, BAGNOLI VR: A multicentre study of the efficacy and tolerability of aceclofenac in the treatment of primary dysmenorrhoea.\ Rev Bras. Med. (1999) 56:169–173.
   Google Scholar
• KOBERLE G, COUTO MAGALHAES AA, JANSEN PACCOLA CA et al: Multicentre, open study of the use of aceclofenac 100 mg, twice a day, in the treatment of muscular-skeletal traumas. Rev Bras. Med. (1998) 55:63–69.
   Google Scholar
• ISHIDA A, ADAMES MK: Study of theefficacy and tolerability of aceclofenac in the treatment of post-traumatic acute process in orthopaedics and traumatology. Rev Bras. Med. (1997) 54:687–693.
   Google Scholar
• CALIN A, MURRAY FE: Aceclofenac: side effects and safety. Ear: J. Animate]. Inflamm. (1996) 16:13–16.
   Google Scholar
• PERTS F, BIRD HA, SERNI U et al: Treatment compliance and safety of aceclofenac versus standard NSAIDs in patients with common arthritic disorders: a meta-analysis. Ear J. Animate]. Inflamm. (1996) 16:37–45.
   Google Scholar
• YANAGAWA A, ENDO T, KUSAKARI K, KUDO T, SHIMADA J, MIZUSHIMA Y: Endoscopic evaluation of aceclofenac-induced gastroduodenal mucosal damage: a double-blind comparison with sodium diclofenac and placebo. Jpnj Animate]. (1998) 8:249–259.
   Google Scholar
• WASSIF W, BJARNASON I: A comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss. Br: J. Clin. Res. (1992) 3:109–114.
   Google Scholar
• LLORENTE MELERO MJ, TENIAS BURILLO JM, ZARAGOZA MARCET A: Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs. Rev Ecp. Enferm. Dig. (2002) 94:7–18.
   PubMed Web of Science ®Google Scholar
• LEMMEL E-M, LEEB B, DE BAST J, ASLANIDIS S: Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study. Carr. Med. Res. Opin. (2002) 18:146–153.
   PubMed Web of Science ®Google Scholar
• PERIS F, MARTINEZ E, BADIA X, BROSA M: Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs. Pharmaceecenemics (2001) 19:779–790.
   Google Scholar
• EVANS C: The use of consensus methods and expert panels in pharmacoeconomic studies: practical applications and methodological limitations. Pharmaceecenemics (1997) 12:121–129.
   Google Scholar
• LANE NE, THOMPSON JM: Management of osteoarthritis in the primary-care setting: an evidence-based approach to treatment. Am. J. Med. (1997) 103(Suppl. 6A):25–30.
   Google Scholar
• CREAMER P, HOCHENBERG MC: Osteoarthritis. Lancet (1997) 350:503-509. Affiliation Professor Erik Legrand Service Rheumatologie, CHU Angers,4 rue Larrey 49933, Angers Cedex 9, France Tel: +33 241 35 35 72; Fax: +33 241 35 37 00; E-mail: [email protected]
   Google Scholar